Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
about
Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)Fluoroquinolones for treating tuberculosisFluoroquinolones for treating tuberculosisEffects of Fluroquinolones in Newly Diagnosed, Sputum-Positive Tuberculosis Therapy: A Systematic Review and Network Meta-AnalysisQuality of outcome reporting in phase II studies in pulmonary tuberculosisIn vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugsAlterations in macromolecular composition and cell wall integrity by ciprofloxacin in Mycobacterium smegmatisTuberculosis: 9. Treatment.Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trialDetection of viable Mycobacterium tuberculosis by reverse transcriptase-strand displacement amplification of mRNAMulticenter laboratory validation of susceptibility testing of Mycobacterium tuberculosis against classical second-line and newer antimicrobial drugs by using the radiometric BACTEC 460 technique and the proportion method with solid media.Successful outcomes with oral fluoroquinolones combined with rifampicin in the treatment of Mycobacterium ulcerans: an observational cohort studyThe bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis.Fluoroquinolones and tuberculosis.Recent developments in the treatment of tuberculosis.Tuberculosis in the AIDS eraRisk factors for acquisition of drug resistance during multidrug-resistant tuberculosis treatment, Arkhangelsk Oblast, Russia, 2005-2010.New regimens for reducing the duration of the treatment of drug-susceptible pulmonary tuberculosis.Early bactericidal activity of antituberculosis agents.Optimizing outpatient serial sputum colony counting for studies of tuberculosis treatment in resource-poor settings.Fluoroquinolones for the treatment of pulmonary tuberculosis.Comparing the efficacy of drug regimens for pulmonary tuberculosis: meta-analysis of endpoints in early phase clinical trials.Tuberculosis in children: an update.Pharmacodynamic evidence that ciprofloxacin failure against tuberculosis is not due to poor microbial kill but to rapid emergence of resistance.Early bactericidal activity of isoniazid in pulmonary tuberculosis. Optimization of methodology. The DATRI 008 Study Group.Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis.A reiterative method for calculating the early bactericidal activity of antituberculosis drugs.Ciprofloxacin once daily versus twice daily for the treatment of pulmonary tuberculosis.Effect of subinhibitory concentrations of ciprofloxacin on Mycobacterium fortuitum mutation rates.The early bactericidal activity of ciprofloxacin in patients with pulmonary tuberculosis.The early bactericidal activity of isoniazid related to its dose size in pulmonary tuberculosis.Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy.
P2860
Q24202081-F8878469-A1D4-4BA5-A6D5-8E07668C0618Q24242773-D08DBE32-41E9-4E8E-BFB2-17DA12E1564BQ24246311-E6E5AAB4-6D0B-4244-A4A5-98BDC21E0E4AQ26775757-C0E77DD1-201A-45E2-8F50-A8263ABDB9BDQ26777160-10C33630-0138-4120-966A-8C67085726FAQ28344608-ACEA7981-CA27-4DD1-8F77-8D9C9603DBE1Q28373280-B9F2E932-4223-494C-9C3F-5EBB83BAEFBCQ33729210-D21D59CC-2768-4A2A-AB15-2BADBB5B8121Q33793948-3076D789-8E43-4D63-ABEA-12A4E82337B2Q33959104-BF2E13A8-BADC-49F0-A067-8474C66090BAQ33962909-8E10A97A-0061-4411-A890-459B01F50858Q34137837-F6D0B5B6-9006-4D05-8222-9C1B40EA109BQ34222223-171C7E9F-81CB-4785-9508-26D0BD4740F6Q34519143-7B873BDB-9F7F-4A5A-95BD-3B0C5CA8CF01Q35185753-37EE6381-99CB-48EA-B9BB-7BBBF75D621FQ35365963-0B0145D9-79E9-45D9-9629-8C94B99DEE7AQ35673493-330B0679-EAD9-4E3A-BB16-CDAB64879076Q35676180-75F28893-1C2B-4779-8F42-720B113E5F47Q35917156-0F939C62-D0A9-4333-9E42-B4DF89673ACFQ36118822-D6ECD21D-78A4-4471-B831-9ACD029A14EFQ36947043-94A2EBA3-1E97-41C3-A533-C2F727E5EC88Q38731369-46B3D5EF-1DF3-4DD0-83B2-476C679F2043Q41177571-96F5A2C5-418D-48D3-9C5C-8F001F3C2D72Q41876123-1CB8ECA1-E101-4F8A-B02F-DA4D5FD9C3EAQ42547475-ABD13319-ADFF-488A-A466-09207335FBBCQ44007889-AF97EB8E-2C99-44D7-9712-C8A19EED7B4EQ44045812-19A0F4AE-DF8A-49F2-A0A0-665A7405BAAEQ44777989-09FF8EBB-58D7-4E94-B0FF-61E70047790FQ46546957-25FEAC16-4D6D-4A4E-92B0-BD9A5CF92E6CQ46802151-A5A6378D-DB2F-4655-A373-F02932B6BEC9Q46804015-CB5A398B-2444-488C-8EC0-6A51729FCA55Q47328162-3C850C4E-4456-48B7-8774-F8244C6D042D
P2860
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
@en
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
@nl
type
label
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
@en
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
@nl
prefLabel
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
@en
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis.
@nl
P2093
P2860
P356
P1476
Early bactericidal and sterilizing activities of ciprofloxacin in pulmonary tuberculosis
@en
P2093
Gillespie SH
Kisyombe GM
P2860
P304
P356
10.1164/AJRCCM/148.6_PT_1.1547
P433
P577
1993-12-01T00:00:00Z